INESSS Introduces New Pre-NOC and Biosimilar Guidance
The Institut national d’excellence en santé et en services sociaux (INESSS) released its new submission guidelines on June 2nd, 2017. … read more »
Canada’s Cancer Drugs – More Hype Than Hope?
Many new cancer drugs are prohibitively expensive but offer patients more hype than hope. The gold-standard for testing medicines is … read more »
Canadian Annual Drug Market Entry Report

The PMPRB published the first edition of Meds Entry Watch, a new annual publication that provides information on recently launched drugs … read more »
Canada Proposes to Revise International Reference Pricing Basket
In a bid to reduce medicine prices in Canada, the Canadian Minister of Health announced the revision of the reference … read more »
CADTH Publishes 4th Edition Guidelines for Economic Evaluation of Health Technologies in Canada

The fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada reflects the experience gained through using the … read more »
MAP BioPharma Launches MAP Canada

MAP BioPharma has just launched MAP Canada! This exciting new addition to the MAP site provides an overview of the market … read more »